Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020148 · ClinicalTrials.gov registry record
Can Oxytocin Level Predict Postpartum Depression?
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 68
- Enrollment target
NCT02020148: Completed study, sponsored by Northwestern University.
NCT02020148 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02020148 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
The goal of this research study is to understand the relationship between the hormone oxytocin and postpartum mood.
Primary Outcome
The IDS-SR-30 is a validated, widely used tool to evaluate depressive symptoms and clinical depression. Participants will complete this questionnaire in person or through telephone interview.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-08 |
What the finished NCT02020148 record still lists
NCT02020148 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02020148 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02020148 about?
NCT02020148 is a clinical study titled "Can Oxytocin Level Predict Postpartum Depression?". The goal of this research study is to understand the relationship between the hormone oxytocin and postpartum mood.
What is the current status of trial NCT02020148?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2013-12. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02020148?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia